Showing results (1-10 of 147) with videos related to
Sort By:
Pageof 15
Cancer Science|January 23, 2015
Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapiesHironori Harada, Yuka Harada[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 4, 2016
[Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment]Yuka Harada, Hironori HaradaCritical Reviews in Eukaryotic Gene Expression|January 5, 2006
Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndromeHironori Harada, Yuka HaradaJournal of Cellular Biochemistry|January 27, 2011
Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutationsYuka Harada, Hironori HaradaJournal of Cellular Physiology|April 1, 2009
Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutationsYuka Harada, Hironori HaradaNihon Rinsho. Japanese Journal of Clinical Medicine|October 29, 2009
[Molecular mechanisms in myeloproliferative diseases and myelodysplastic syndromes]Hironori Harada, Yuka Harada, Akiro KimuraLeukemia|March 31, 2022
Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspectiveYoshihiro Hayashi, Yuka Harada, Hironori HaradaCurrent Cancer Drug Targets|October 5, 2006
Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDSHironori Harada, Yuka Harada, Akiro KimuraInternational Journal of Hematology|May 24, 2017
Myeloid neoplasms with germ line RUNX1 mutationYoshihiro Hayashi, Yuka Harada, Gang Huang, et al.Frontiers in Oncology|October 3, 2022
Adult-onset hereditary myeloid malignancy and allogeneic stem cell transplantationTakashi Toya, Hironori Harada, Yuka Harada, et al.Pageof 15